GE Healthcare has announced the formation of the “GE Healthymagination Fund”, which will make investments in promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT and life sciences technologies aligned with the initiative's strategic objectives. The fund will also support healthcare companies developing business models and services.
The formation of the fund is part of GE’s global $6 billion Healthymagination initiative, which aims to deliver better healthcare to more people at lower cost. The fund will target three broad areas for investment:
Broad-based diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies.
Healthcare information technology, including electronic medical records, clinical information systems, healthcare information exchanges and value-added data services.
Life sciences, including tools for research and development in biopharmaceuticals and stem cells, and technologies for manufacturing biopharmaceuticals and vaccines.
The fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research.
“The creation of the GE Healthymagination Fund reaffirms our commitment to innovation in healthcare to bring better health to more people,” said GE Chairman and CEO Jeffrey Immelt. “As GE works on solutions to healthcare’s biggest challenges, it is vitally important that we support the development of companies with promising technologies or business models that are aligned with our strategy and have the potential to shape the future of healthcare."
For further information about the fund, visit http://www.healthymaginationfund.com.